Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01206452 · ClinicalTrials.gov registry record · Phase 4
Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes
A Phase 4 study, sponsored by Dhanunjaya Lakkireddy, MD, FACC.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT01206452: Completed Phase 4 study, sponsored by Dhanunjaya Lakkireddy, MD, FACC.
NCT01206452 is a Phase 4 study that has completed, run by Dhanunjaya Lakkireddy, MD, FACC. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01206452, a Phase 4 study, has completed, sponsored by Dhanunjaya Lakkireddy, MD, FACC.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation.
Primary Outcome
Number of AF recurrences between the two study groups as assessed by 1-month event monitor placed at 6 and 12 months post-ablation. Any episode of AF lasting greater than 30 seconds was counted as a recurrence.
Interventions
- OTHER Placebo
- DRUG Prednisone
- PROCEDURE Ablation Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
What the finished NCT01206452 record still lists
NCT01206452 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01206452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01206452 about?
NCT01206452 is a clinical study titled "Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes". The primary purpose of this study is to assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation.
What is the current status of trial NCT01206452?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2010-09. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01206452?
The interventions under investigation include: Placebo (OTHER), Prednisone (DRUG), Ablation Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT01206452?
This trial is sponsored by Dhanunjaya Lakkireddy, MD, FACC, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01206452's enrollment target sits among peer trials
60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia